Results 201 to 210 of about 74,341 (223)

Progression-Free Survival in Gastrointestinal Stromal Tumours With High-Dose Imatinib: Randomised Trial

Lancet, The, 2004
Jean-Yves Blay, Ian Judson
exaly  

Imatinib Treatment Duration Is Related to Decreased Estimated Glomerular Filtration Rate in Chronic Myeloid Leukemia Patients

Annals of Oncology, 2011
Teun van Gelder, Milena Soriano Marcolino, K M Akkerhuis   +2 more
exaly  

Imatinib

Reactions Weekly, 2019
  +4 more sources

Results of Plasma N-Terminal Pro B-Type Natriuretic Peptide and Cardiac Troponin Monitoring in GIST Patients Do Not Support the Existence of Imatinib-Induced Cardiotoxicity

Annals of Oncology, 2008
Jourik A. Gietema, W T A van der Graaf, W T A van der Graaf   +2 more
exaly  

Post-Imatinib Surgery in Advanced/Metastatic GIST: Is It Worthwhile in All Patients?

Annals of Oncology, 2010
Marco Fiore, Elena Tamborini, Alessandro Gronchi   +2 more
exaly  

Prevalence, Determinants, and Outcomes of Nonadherence to Imatinib Therapy in Patients With Chronic Myeloid Leukemia: The ADAGIO Study

Blood, 2009
Koen Van Eygen, Tara Albrecht, Pierre Zachee   +2 more
exaly  

Imatinib

Reactions Weekly, 2023
openaire   +1 more source

Dasatinib or High-Dose Imatinib for Chronic-Phase Chronic Myeloid Leukemia After Failure of First-Line Imatinib: A Randomized Phase 2 Trial

Blood, 2007
Timothy Hughes, Hagop Kantarjian, Tadeusz Robak   +2 more
exaly  

Imatinib

Reactions Weekly, 2017
openaire   +1 more source

Sunitinib for Imatinib-Resistant GIST

Lancet, The, 2006
Heikki Joensuu
exaly